Generoso Andria Selected Research

migalastat

1/2014	Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease.
5/2012	Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease.
6/2009	The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Generoso Andria Research Topics

Disease

10	Glycogen Storage Disease Type II (Pompe's Disease) 11/2014 - 03/2007
7	Muscular Diseases (Myopathy) 12/2012 - 03/2007
6	Down Syndrome (Down's Syndrome) 12/2016 - 07/2006
6	Gaucher Disease (Gaucher's Disease) 11/2014 - 02/2004
5	Glycogen Storage Disease (Glycogenosis) 01/2017 - 04/2010
5	Lysinuric Protein Intolerance 02/2011 - 08/2004
4	Lathosterolosis 07/2015 - 10/2002
3	Homocystinuria 01/2017 - 03/2007
3	Chondrodysplasia Punctata (Stippled Epiphyses) 07/2015 - 03/2003
3	Phenylketonurias (Phenylketonuria) 02/2015 - 04/2009
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2015 - 06/2009
3	Intellectual Disability (Idiocy) 01/2014 - 10/2002
3	Fabry Disease (Fabry's Disease) 01/2014 - 06/2009
2	Hyperlipidemias (Hyperlipidemia) 05/2016 - 04/2015
2	Infections 01/2016 - 08/2005
2	Neutropenia 01/2016 - 08/2005
2	Metabolic Diseases (Metabolic Disease) 07/2015 - 12/2013
2	Desmosterolosis 07/2015 - 01/2005
2	HEM dysplasia 07/2015 - 01/2005
2	Chromosome Aberrations (Chromosome Abnormalities) 07/2015 - 01/2006
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 07/2015 - 03/2003
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 07/2015 - 06/2015
2	Disease Progression 02/2015 - 02/2004
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 02/2015 - 03/2011
2	Neurologic Manifestations (Neurological Manifestations) 02/2015 - 03/2011
2	Hyperhomocysteinemia 09/2014 - 05/2013
2	Deglutition Disorders (Dysphagia) 05/2013 - 03/2011
1	COVID-19 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Thromboembolism 01/2017
1	Inflammation (Inflammations) 12/2016
1	Metabolic Bone Diseases (Osteopenia) 05/2016
1	Glycogen Storage Disease Type III (Cori's Disease) 05/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015
1	Hepatorenal form of glycogen storage disease 07/2015
1	Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects 07/2015
1	Brachytelephalangic Chondrodysplasia Punctata 07/2015
1	Congenital Abnormalities (Deformity) 07/2015
1	Autoimmune Diseases (Autoimmune Disease) 07/2015
1	Peroxisomal Disorders (Peroxisomal Disorder) 07/2015
1	Rhizomelic Chondrodysplasia Punctata 07/2015
1	Antley-Bixler Syndrome Phenotype 07/2015
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 06/2015
1	Propionic Acidemia 06/2015
1	Methylmalonic acidemia 06/2015
1	Medium chain acyl CoA dehydrogenase deficiency 06/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2015
1	Isobutyryl-CoA dehydrogenase deficiency 06/2015

Drug/Important Bio-Agent (IBA)

9	EnzymesIBA 07/2015 - 03/2007
6	AcidsIBA 11/2014 - 05/2007
5	GlycogenIBA 01/2017 - 03/2007
5	miglustat (Zavesca)FDA Link 02/2015 - 03/2007
5	alpha-Glucosidases (Acid Maltase)IBA 12/2009 - 03/2007
4	HomocysteineIBA 01/2017 - 07/2006
4	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2017 - 07/2006
4	CholesterolIBA 07/2015 - 01/2005
4	HydrolasesIBA 07/2015 - 03/2007
4	GlucosidasesIBA 11/2014 - 03/2007
4	Folic Acid (Vitamin M)FDA LinkGeneric 05/2013 - 05/2002
4	Amino Acids FDA Link 02/2011 - 04/2005
3	Oxidoreductases (Dehydrogenase)IBA 07/2015 - 05/2002
3	Proteins (Proteins, Gene)FDA Link 07/2015 - 08/2005
3	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 02/2015 - 04/2009
3	migalastatIBA 01/2014 - 06/2009
3	Glucosylceramidase (Glucocerebrosidase)IBA 11/2012 - 02/2004
3	Glucosylceramides (Glucocerebrosides)IBA 11/2012 - 02/2004
2	CystathionineIBA 01/2017 - 09/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 07/2015
2	Glucose-6-PhosphateIBA 01/2017 - 03/2014
2	LipidsIBA 04/2015 - 03/2011
2	Coenzymes (Enzyme Cofactors)IBA 02/2015 - 03/2013
2	sapropterin (tetrahydrobiopterin)FDA Link 02/2015 - 03/2013
2	Phenylalanine (L-Phenylalanine)FDA Link 02/2015 - 03/2013
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2014 - 07/2006
2	Growth Hormone (Somatotropin)IBA 03/2014 - 04/2010
2	5,10-methylenetetrahydrofolic acidIBA 05/2013 - 05/2002
2	Lysergic Acid Diethylamide (LSD)IBA 01/2013 - 12/2009
2	agalsidase alfaIBA 05/2012 - 06/2009
2	Imino SugarsIBA 03/2007 - 03/2007
1	Methionine (L-Methionine)FDA Link 01/2017
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	Citric Acid (Citrate)FDA LinkGeneric 12/2016
1	Insulin (Novolin)FDA Link 05/2016
1	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 05/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 05/2016
1	Vitamin E FDA LinkGeneric 01/2016
1	emopamil (levemopamil)IBA 07/2015
1	Carrier Proteins (Binding Protein)IBA 07/2015
1	SqualeneIBA 07/2015
1	SterolsIBA 07/2015
1	Vitamin K FDA Link 07/2015
1	Beta ketothiolase deficiencyIBA 06/2015
1	Systemic carnitine deficiencyIBA 06/2015
1	Glutamate Formimidoyltransferase (Glutamate Formiminotransferase)IBA 06/2015
1	Branched-Chain Amino AcidsIBA 06/2015

Therapy/Procedure

16	Therapeutics 01/2022 - 03/2007
6	Enzyme Replacement Therapy 11/2014 - 10/2004
2	Enzyme Therapy 11/2014 - 02/2004
1	Personal Protective Equipment 01/2022